ZLAB Zai Lab Limited
Zai Lab Limited (ZLAB) is expected to report earnings on November 5, 2026, before the market open. The stock has had a Post-Earnings Announcement Drift (PEAD) of +36.0% since its last earnings release on August 6, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Zai Lab Limited
Zai Lab is a patient-focused, innovative, commercial-stage, global biopharmaceutical company focused on developing and commercializing therapies that address medical conditions with unmet needs in oncology, autoimmune disorders and infectious disease.
Sector
Healthcare
Industry
Biotechnology